Patient engagement in clinical trials is no longer a “nice to have”—it is essential to designing research that is relevant, inclusive, and impactful. This growing priority was highlighted at the Clinical Trials Symposium 2026, where leaders in patient-oriented research shared practical approaches to strengthening collaboration between researchers and people with lived experience.
Among the presenters was Lucy Kovalova-Woods, Founder of WKG Foundation and Board Member at CAPA, alongside Linda Hunter, Patient Partner and Governing Council Member with CANTRAIN. Representing Canadian Arthritis Patient Alliance (CAPA) and WKG Foundation, they presented a poster titled “A Practical Framework for Meaningful Patient Partner Engagement in Clinical Trials.”
Their work focused on a critical shift in research—from limited or symbolic patient involvement toward meaningful, sustained partnership across the clinical trial lifecycle. The framework introduced three key pillars: accessibility, reciprocity, and operational integration. Together, these principles emphasize removing barriers to participation, valuing lived experience as essential expertise, and embedding patient partners into core processes such as study design, recruitment, outcome selection, and knowledge translation.
This approach reflects a broader transformation in patient-oriented research. When patients are actively engaged as partners, clinical trials become more relevant to real-world needs, recruitment and retention improve, and research outcomes are more likely to translate into meaningful health improvements. Patient engagement also strengthens trust, accountability, and transparency within the research process.
For WKG Foundation, this work aligns directly with its mission to advance inclusive systems that connect lived experience with strategy, education, and innovation. By advocating for stronger patient engagement in clinical trials, the Foundation supports a future where research is more accessible, equitable, and impactful.
As momentum continues to build globally, one message stands out clearly: effective clinical trials are built through partnership. Leaders like Lucy Kovalova-Woods and Linda Hunter are helping shape a future where patients are not simply participants—but active contributors to research, policy, and healthcare transformation. For WKG Foundation it means developing one more meaningful career transition pathway, as well as advancing patient engagement in multiple aspects of research, healthcare, etc.